Influence of shunt occlusion on liver volume and functions in hyperammonemic cirrhosis patients having large porto-systemic shunts: a randomized control trial
- 12 September 2022
- journal article
- research article
- Published by Springer Nature in Hepatology International
- Vol. 17 (1) , 150-158
Abstract
Background and aims Spontaneous-portosystemic-shunts (SPSS) in cirrhosis deprive the liver of nutrient-rich portal blood and contribute to recurrent hepatic encephalopathy (HE). We evaluated the effects of shunt occlusion and redirecting portal blood to liver on its volume and functions. Methods Cirrhosis patients presenting with recurrent HE and having SPSS were randomized to receive standard medical treatment (SMT) or shunt occlusion (SO). The later was performed by plug-assisted or balloon-occluded retrograde transvenous obliteration. The primary endpoint was change in liver volume after a minimum follow-up of 3 months. Secondary objectives included clinical course, liver disease severity indices, arterial ammonia levels and bone density. Results Of 40 enrolled patients, 4 in SMT and 2 in SO group were lost to follow-up. The SO was complete in 17 and partial in one, achieving non-recurrence of HE in 17 (94.4%). In these patients, the mean liver volume increased (baseline 1040 ± 335 ml to 1132 ± 322 ml, 8.8% increase, p < 0.001) and was observed in 16/18 (88.89%) patients. In the SMT group, the liver volume decreased (baseline 988 ± 270 ml to 904 ± 226 ml, 8.6% reduction, p = 0.009) during the same period. Serum albumin increased in SO group (2.92 ± 0.40 g/dl to 3.30 ± 0.49 g/dl, p = 0.006) but reduced in SMT group (2.89 ± 0.43 g/dl to 2.59 ± 0.65 g/dl, p = 0.047). After SO, the patients showed a reduction in serum-ammonia levels (181.06 ± 86.21 to 107.28 ± 44.53 μ/dl, p = 0.001) and an improvement in MELD-Na and bone density compared to SMT group. There were no major adverse events following shunt occlusion. Conclusion Occlusion of large SPSS results in improving the volume and synthetic functions of the liver by restoring hepato-petal portal flow besides reducing serum-ammonia level and recurrence of HE. ClinicalTrials.gov number, NCT03293459.Keywords
This publication has 24 references indexed in Scilit:
- Gastric Varices and Hepatic Encephalopathy: Treatment with Vascular Plug and Gelatin Sponge–assisted Retrograde Transvenous Obliteration—A Primary ReportRadiology, 2013
- Introduction: BRTO & BATOTechniques in Vascular and Interventional Radiology, 2013
- Chapter 1: Definition and classification of CKDKidney International Supplements, 2013
- Efficacy of Balloon-occluded Retrograde Transvenous Obliteration of Large Spontaneous Lienorenal Shunt in Patients with Severe Recurrent Hepatic Encephalopathy with Foam Sclerotherapy: Initial ExperienceJournal of Vascular and Interventional Radiology, 2012
- EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosisJournal of Hepatology, 2010
- Mechanisms of Hepatic Regeneration Following Portal Vein Embolization and Partial Hepatectomy: A ReviewWorld Journal of Surgery, 2007
- Change in the Hemodynamics of the Portal Venous System After Retrograde Transvenous Balloon Occlusion of a Gastrorenal ShuntAmerican Journal of Roentgenology, 2003
- Liver RegenerationJournal of the American College of Surgeons, 2003
- Hemodynamic changes in portal circulation after portosystemic shunts: use of duplex sonography in 43 patientsAmerican Journal of Roentgenology, 1987
- Accurate Measurement of Liver, Kidney, and Spleen Volume and Mass by Computerized Axial TomographyAnnals of Internal Medicine, 1979